Tag: RCT
ECR 2022: Interventional oncology is the fourth pillar of oncology—a shift...
With cancer cases growing worldwide and an increased number of late-stage diseases in elderly patients, there is an increasing need for an integrated approach....
Six-month registry interim data flash early thrombectomy safety in pulmonary embolism...
Inari Medical has announced positive acute and long-term interim results from the first 500 pulmonary embolism patients enrolled in the FlowTriever outcomes registry (FLASH).
A...
CAVA RCT delivers powerful evidence supporting use of PORTs to supply...
For most patients receiving systemic anticancer treatment (SACT), totally implanted ports (PORTs) are more effective and safer than both Hickman-type tunnelled catheters (Hickman) and...
Impressions from LINC 2020: Strong clinical and economic case for widespread...
NOTE: This video is ONLY available to watch in selected countries and geographies
Andrew Holden (Auckland, New Zealand), Alexandros Mallios (Paris, France), Robert Lookstein (New...
Experts discuss latest results from EFFPAC and TINTIN trials presented at...
NOTE: ONLY intended for healthcare professionals outside of the USA.
Ulf Teichgräber (Jena, Germany) and Koen Deloose (Dendermonde, Belgium) discuss the 24-month results of the...
Cook leads the way to data transparency with release of long-term...
There were calls for greater transparency and sharing of the available randomised controlled trial data of paclitaxel-coated devices at the CX 2019 Highlight Session, Paclitaxel:...
VERTOS IV raises doubts about vertebroplasty
Percutaneous vertebroplasty does not result in statistically significant greater pain relief than a sham procedure, reports a study detailing the results of the VERTOS...
SIRT fails to extend survival in the SORAMIC study palliative cohort
The SORAMIC study, presented at The International Liver Congress, shows that the addition of selective internal radiation therapy (SIRT) to sorafenib in patients with...
First data from head-to-head comparison of Ranger and IN.PACT drug-coated balloons...
Early data from the first randomised controlled trial to compare two drug-coated balloons (DCBs) suggest that the primary patency obtained with the Ranger DCB...
One-year MIMICS-2 results show BioMimics 3D stent results in nearly 90%...
Thomas Zeller (Bad Krozingen, Germany) presented the 12-month results from Veryan Medical’s MIMICS-2, a prospective, single arm, multicentre clinical study to evaluate the safety...
Brave Dreams trial finds venous angioplasty “safe, but largely ineffective” for...
Paolo Zamboni, Ferrara, Italy, the proponent of the chronic cerebrospinal venous insufficiency (CCSVI) theory, and his colleagues have reported that the randomised, double-blinded, sham...
Theoretical benefit with microwave ablation “does not translate into clinical benefit”...
A prospective randomised controlled study that compared outcomes between hepatocellular carcinoma patients who were treated by microwave ablation with those who were treated by...
CAVA trial to shed light on clinical and cost-effectiveness of routinely...
The world’s largest randomised trial comparing three central venous access devices—peripherally inserted central catheters (PICCs), Hickman-type devices and chest wall ports—should provide definitive results...
ATTRACT fails to meet primary endpoint, but experts agree results are...
Data from the randomised controlled ATTRACT trial revealed that the addition of catheter-based intervention to standard-of-care anticoagulation failed to significantly decrease the occurrence of...
ATTRACT trial results to be presented at SIR 2017 meeting
Suresh Vedantham, professor of Radiology and Surgery, Mallinckrodt Institute of Radiology, Washington University School of Medicine in St Louis, USA, is scheduled to present the...
New ESMO biliary cancer guidelines indicate radioembolization as an option for...
New European Society of Medical Oncology (ESMO) biliary cancer guidelines indicate yttrium-90 (Y-90) therapy as an option for post-chemotherapy treatment of intrahepatic cholangiocarcinoma.
Sirtex has announced...
Majority of patients treated with embolization for symptomatic fibroids can avoid...
Ten-year outcomes from the randomised controlled EMMY trial were presented at CIRSE 2016 (10–14 September, Barcelona, Spain) by Jim Reekers, Academic Medical Center, Amsterdam,...
